Lv4
580 积分 2025-03-27 加入
How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor
4天前
已完结
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens
4天前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
4天前
已完结
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
4天前
已完结
Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis
4天前
已完结
Germline CDK12 variants in aggressive prostate cancer
9天前
已完结
Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer
10天前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
11天前
已完结
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial
11天前
已完结
Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: Pancreaticoduodenectomy
12天前
已完结
皖公网安备34019202002308
